FDA Adverse Event Injury Summary report: N

VERCISE GEVIA

MDR report key: 12096996 · Received June 30, 2021

Report

Report Number
3006630150-2021-03376
Event Type
Injury
Date Received
June 30, 2021
Date of Event
May 25, 2021
Report Date
June 30, 2021
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2202300, MODEL: DB-2202-30, SERIAL: (B)(4), BATCH: 7072371. PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2202300, MODEL: DB-2202-30, SERIAL: (B)(4), BATCH: 7072369.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT IN THE CLINICAL STUDY FOR DEPRESSION EXPERIENCED ABDOMINAL PAIN SIX DAYS AFTER A DBS DEEP BRAIN STIMULATOR IMPLANT PROCEDURE. THE LABORATORY EVALUATION REVEALED ELEVATED D-DIMERS AND THE CONTRAST ENHANCED COMPUTED TOMOGRAPHY CT SCAN REVEALED A PULMONARY EMBOLISM PE. COMPRESSION STOCKINGS AND ANTITHROMBOTIC PHARMACOLOGY HAD BEEN ADMINISTERED AS ANTITHROMBOTIC MEASURES TAKEN PRIOR TO THE PROCEDURE AS THIS PATIENT HAD EXPERIENCED A PRIOR PE. FOLLOWING THE PROCEDURE, THE PATIENT WAS ADMINISTERED THE ANTICOAGULANT HEPARIN AND IS IN STABLE CONDITION. IT WAS NOTED THAT PRIOR TO THE PROCEDURE, THE PATIENT SPENT AN UNUSUAL AMOUNT OF TIME INACTIVE IN OR ON HIS BED, DUE TO DEPRESSION. THE PHYSICIAN EVALUATED THAT THE PE WAS NOT DUE TO THE MEDICAL DEVICE OR TO AN INCREASED PROPENSITY OF THE CLINICAL STUDY EXPERIMENT. THE PHYSICIAN ASSESSED THAT THE PE WAS RELATED TO THE SURGICAL PROCEDURE AN NOTED THAT A PULMONARY EMBOLISM CAN BE A RISK OF ANY SURGICAL OR ANESTHETIC INTERVENTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
986983 VERCISE GEVIA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY BOSTON SCIENTIFIC NEUROMODULATION DB-1200 744665

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention